107 related articles for article (PubMed ID: 6796187)
1. Prostaglandin I2 and E1 and red cell deformability in raynaud's phenomenon and systemic sclerosis.
Gaylarde PM
Br Med J (Clin Res Ed); 1981 Dec; 283(6306):1608-9. PubMed ID: 6796187
[No Abstract] [Full Text] [Related]
2. Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis.
Dowd PM; Kovacs IB; Bland CJ; Kirby JD
Br Med J (Clin Res Ed); 1981 Aug; 283(6287):350. PubMed ID: 6788326
[No Abstract] [Full Text] [Related]
3. Assessment of platelet function in patients with Raynaud's syndrome.
Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
[TBL] [Abstract][Full Text] [Related]
4. Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.
Lucas GS; Simms MH; Caldwell NM; Alexander SJ; Stuart J
J Clin Pathol; 1984 Aug; 37(8):870-3. PubMed ID: 6540787
[TBL] [Abstract][Full Text] [Related]
5. The effect of prostaglandins E1, I2 and F2 alpha on the shape and phosphatidylinositol-4,5-bisphosphate metabolism of washed rabbit platelets.
Vickers JD; Kinlough-Rathbone RL; Mustard JF
Thromb Res; 1982 Dec; 28(6):731-40. PubMed ID: 6301091
[No Abstract] [Full Text] [Related]
6. Erythropoietic effects of prostacyclin (PGI2) and its metabolite 6-keto-prostaglandin (PG)E1.
Nelson PK; Brookins J; Fisher JW
J Pharmacol Exp Ther; 1983 Aug; 226(2):493-9. PubMed ID: 6410047
[No Abstract] [Full Text] [Related]
7. Prostaglandin I2 fails to influence red cell deformability.
Slott JH; Hall K; Clark DA; Stuart MJ
Prostaglandins Leukot Med; 1982 Jan; 8(1):21-2. PubMed ID: 7043490
[No Abstract] [Full Text] [Related]
8. Peripheral vasodilator effects of prostaglandins: comparison of 6-keto-prostaglandin E1 with prostacyclin and escape from prostaglandin E2 in the mesenteric vascular bed.
Feigen LP; Chapnick BM; Hyman AL; King L; Marascalco B; Kadowitz PJ
J Pharmacol Exp Ther; 1980 Sep; 214(3):528-34. PubMed ID: 6995573
[No Abstract] [Full Text] [Related]
9. Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis.
Martin MF; Tooke JE
Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1688-90. PubMed ID: 6816332
[TBL] [Abstract][Full Text] [Related]
10. Cyclic adenine nucleotide levels in lymphocytes from patients with systemic sclerosis: efficiency of prostaglandin infusions.
Kovacs IB; Dowd PM; Kirby JD; Turner P
Postgrad Med J; 1983 Apr; 59(690):241-3. PubMed ID: 6306626
[TBL] [Abstract][Full Text] [Related]
11. The influence of catecholamines and prostaglandins on calcium efflux and filtrability of thermally damaged erythrocytes: an in vitro study.
Baar S
Br J Exp Pathol; 1982 Dec; 63(6):644-50. PubMed ID: 6960925
[TBL] [Abstract][Full Text] [Related]
12. [New treatments for Raynaud's syndrome].
Bellucci S; Kedra W; Ajzenberg N; Tobelem G; Caen J
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):103-7. PubMed ID: 3290833
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe Raynaud's phenomenon with prostaglandin E1.
Allen JA; O'Reilly MJ
Ir J Med Sci; 1981 Jun; 150(6):190-1. PubMed ID: 7275566
[No Abstract] [Full Text] [Related]
14. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N
Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
[TBL] [Abstract][Full Text] [Related]
15. [Effect of prostaglandins E1, E2, D2, F2 alpha and I2 on the canine airways and pulmonary vascular bed (author's transl)].
Kitamura S; Ishihara Y; Sugiyama Y; Hsu LH
Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Sep; 17(9):560-6. PubMed ID: 393881
[No Abstract] [Full Text] [Related]
16. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin control of plasma and platelet 5-hydroxytryptamine in normal and embolized animals.
Utsunomiya T; Krausz MM; Shepro D; Hechtman HB
Am J Physiol; 1981 Nov; 241(5):H766-71. PubMed ID: 7030086
[No Abstract] [Full Text] [Related]
18. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
Bult H; Wechsung E; Houvenaghel A; Herman AG
Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
[No Abstract] [Full Text] [Related]
19. Effects of indomethacin and prostaglandins E2, I2, and D2 on the fetal circulation.
Sideris EB; Yokochi K; Van Helder T; Coceani F; Olley PM
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():477-82. PubMed ID: 6221634
[No Abstract] [Full Text] [Related]
20. [Effects of prostaglandins E1 and I2 on pulmonary thromboembolism- and hypoxia-induced responses in canine airways and the pulmonary vascular bed (author's transl)].
Kitamura S; Ishihara Y; Sugiyama Y; Hsu LH
Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Aug; 17(8):488-94. PubMed ID: 390192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
